期刊文献+

CAHPl70透析器复用对血透患者血清补体C3、IL-2、TNF-α、NO的影响 被引量:1

Effect of the Reuse of CAHP170 Dialyzer on Dialysis Membrane Biocompatibility
下载PDF
导出
摘要 【目的】探讨CAHPl70透析器复用对透析膜生物相容性的影响。【方法】观察10例维持性血液透析患者在透析器初用和复用时,透前、透析15、120min、透后血清白介素-2(IL-2)、肿瘤坏死因子-α(TNF-α)、补体C3、一氧化氮(NO)的水平。【结果】在透析15min,透析器初用血清IL-2、TNF-α、NO水平较各点显著升高(P〈0.05),复用较初用显著降低(P〈0.05);血清C3水平则较各点显著降低(P〈0.05),复用较初用显著升高(P〈O.05);IL-2、TNF-α、NO水平互相呈正相关(P〈0.05),补体C3与IL-2、TNF-α、NO均呈负相关(P〈0.05)。透后血清N0水平较透前显著降低(P〈0.05)。【结论】透析15min时血清IL-2、TNF-α、NO、补体C3水平可作为判断透析器生物相容性的良好指标。透析器复用后透析膜生物相容性得到明显改善。 [Objective] To investigate the biocompatibility of the reuse of CAHP170 dialyzer. [Methods] Ten regular hemodialysis patients were selected. In the first use and reuse of dialyzer, four time points (pre- dialysis, fifteen minutes, two hours, post-dialysis) were chosen to detect the serum IL-2, TNF-α, comple- ment C3 and NO level. [Results] Serum IL 2, TNF-α and NO level increased significantly( P 〈0.05) and se rum complement C3 level decreased significantly(P〈0.05) at the fifteen minutes after initiation of hemodialy- sis. Compare the first use, the reuse of dailyzer significantly decreased IL-2, TNF-α and NO level ( P 〈0. 05), but increased complement C3 significantly ( P 〈0.05). The NO level after dialysis was significantly low- er than that before dialysis ( P 〈0.05). [Conclusion] On the fifteen minutes of hemodialysis, serum IL-2, TNF-α, complement C3 and NO level are regarded as good markers for membrane biocompatibility. The reuse of hemodialyzer can ameliorate membrane biocompatibility.
出处 《医学临床研究》 CAS 2009年第9期1611-1613,共3页 Journal of Clinical Research
关键词 血液透析/仪器和设备 补体3C/A液 白细胞介素2/血液 肿瘤坏死因子/血液 一氧化氮/血液 hemodialysis/IS complement 3c/BL interleukin-2/BL tumor necrosis factor/BL itric oxide/BL
  • 相关文献

参考文献10

  • 1Mitwalli AH, Abed J, Tarif N, et al . Dialyzer reuse impact on dialyzer efficiency, patient morbidity and mortality and cost effectiveness[J].Saudi J Kidney Dis Transpl ,2001,12 (3) :305-311.
  • 2文煜冰.透析器复用的研究现状[J].国外医学(泌尿系统分册),2002,22(6):353-356. 被引量:10
  • 3Opatrny K, Jr. Clinical importance of biocompatibility and its effect on haemodialysis treatment [J]. Nephrol Dial Transplant ,2003 , 18 Suppl 5 :v41-44.
  • 4Twardowski ZJ. Dialyzer reuse-part II: advantages and disadvantages[J]. Seminars in Dialysis ,2006,19(3):217-226.
  • 5Craddoek PR, Hammerschmidt D, White JG. Complement (CS-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia[J]. J Clin Invest ,1977,60(1):260-264.
  • 6Stroncek DF, Keshaviah P, Craddock PR, et al . Effect of dialyzer reuse on complement activation and neutropenia in he modialysis[J]. J Lab Clin Med , 1984,104(3) :304-311.
  • 7ND Vaziri, J Wang, T Cesario, et al . Induction, transcription, synthesis and adsorption of interleukin 1 by dialyzer memhranes[J]. J Am Soc Nephrol , 1994,4 ( 11 ) : 1884-1889.
  • 8Singh NP, Bansal R, Thakur A, et al . Effect of membrane composition on cytokine production and clinical symptoms during hemodialysis: a crossover study[J]. Renal Failure , 2003 ,25(3) :419-430.
  • 9Sarkar SR, Kaitwatcharachai C, Levin NW. Nitric oxide and hemodialysis[J]. Seminars in Dialysis , 2004 , 17 (3) : 224- 228.
  • 10Pereira BJ, Natov SN, Sundaram S, et al . Impact of single use versus reuse of cellulose dialyzers on clinical parameters and indices of biocompatibility[J]. J Am Soc Nephrol , 1996 , 7(6) :861-870.

共引文献9

同被引文献2

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部